Budecort Inhaler
Intended to relieve airway swelling to support ongoing respiration and mitigate hyperreactive bronchial flares.
- Category
- Respiratory Health
- Active ingredient
- Budesonide
- Route
- Inhalation use
- Form
- Inhaler
- Strengths
- 100mcg · 200mcg
Prescription and consultation requirements for Budecort Inhaler vary by destination and are determined by the fulfilment partner.
Budecort Inhaler details
- Conditions
- Asthma · Chronic Obstructive Pulmonary Disease
- Alternative names
- budesonide
- Therapeutic class
- Glucocorticoid
- Pharmacological class
- Corticosteroid Inhaler
- Contraindications
- status asthmaticus; hypersensitivity to budesonide
- Minor side effects
- throat irritation; cough; hoarseness
- Moderate side effects
- oral thrush; headache; sinusitis
- Dosage forms
- Inhaler
- Administration route
- Inhalation use
- Supply category
- Prescription-only medicine (POM)
- Manufacturer
- Cipla Ltd
- Onset Time
- 1–2 weeks
- Duration
- 12 hours
- Storage instructions
- Store below 25°C.
- Drug interactions
- Ketoconazole; Ritonavir
- Age restrictions
- Approved for children and adults.
Serious side effects
paradoxical bronchospasm, requires immediate medical attention; adrenal insufficiency, requires immediate medical attention
Patient summary
intended to relieve airway swelling to support ongoing respiration and mitigate hyperreactive bronchial flares.
Mechanism of action
Suppresses mucosal inflammation and reduces airway wall thickness by inhibiting local cytokine and prostaglandin synthesis.
Pregnancy and breastfeeding
TGA Category B: Clinically safe based on large epidemiological studies. Breastfeeding: Compatible.